Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 June 2021 | Story Lunga Luthuli | Photo Lunga Luthuli
South Campus: Social Responsibility Project team with Free State Department of Health nurses during the lunch of the campus’ COVID-19 pop-up vaccination site.

On Monday 27 September 2021, the University of the Free State, Provincial Department of Health and Department of Education launched a pop-up vaccination site at the South Campus bringing much-needed services closer to communities in the fight to end the COVID-19 pandemic.

Thandeka Mosholi, Head of Social Responsibility, Enterprise and Community Engagement, South Campus says, “We are next to the Mangaung community and bringing these services we encourage not only UFS staff and students but the surrounding communities to vaccinate for COVID-19. The institution and stakeholders are saying it is everyone’s responsibility for their health.”

She says, “If vaccination is recommended and we are told that it is safe, we encourage everyone including the youth to preserve our health and vaccinate.”

Representing the Department of Health, Papi Mokhele, Professional Pharmacist, says, “The initiative is aimed at reaching out to as many people to be vaccinated.”

He says, “At the moment the facility administers only the Pfizer vaccination and, as recommended by the National Government, we want to reach herd immunity – about 70% of the population – so that businesses, sporting facilities and many others can open and get our life back to normal.”

Other facilities the Department of Health has recently opened include the SABC Hoffman Square, Majakathata Taxi Rank, MUCCPP Health Centre in Phelindaba, Puma Garage in Bergman and Mangaung Outdoor Centre.

On partnering with the UFS, Mokhele says, “The COVID-19 vaccines have been put through clinical processes and quality assurance tests. They have also been approved by the South African Medicine Control Council and we call on the UFS community, especially students, to register and vaccinate.”

Coretha van den Heever, Teacher Trainer in the Social Responsibility Project, was recently vaccinated for the pandemic and says, “Let us protect ourselves and other people and not be the spreaders of the virus.”

She says, “People must make use of the facility; the UFS and government have brought the solution closer so that communities will not have to spend a lot of money travelling to get help.”

The vaccination centre will operate from Monday to Friday from 9:00 to 16:00.

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept